EHS-COVID (282) BMJ Innovation - special issue on the innovations that were developed or matured during COVID-19

8 May, 2021

An editorial by HIFA steering group member Ashley McKimm (BMJ) introduces a speacial issue of BMJ Innovation with a focus on the innovations that were developed or matured during COVID-19.

CITATION: McKimm A. Innovation will help us leave a positive health legacy from COVID-19BMJ Innovations 2021;7:247-248. https://innovations.bmj.com/content/7/2/247

SELECTED EXTRACTS:

'In addition to the paradigm shift in vaccine development, we have seen the widescale adoption of telemedicine and significant leaps forward in the application of artificial intelligence in disease prediction and diagnosis. Many innovations will fail, but many others will also have a lasting impact on health long after we have brought the COVID-19 pandemic under control...

In this issue, we are publishing submissions from our special call for papers on the innovations that were developed or matured during the COVID-19 pandemic, many of which will go on to have a lasting positive impact on health.'

Neil Pakenham-Walsh, HIFA Coordinator, neil@hifa.org www.hifa.org